umbilical cord blood mononuclear cells / Xiangyang 1st people's Hospital 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
umbilical cord blood mononuclear cells / Xiangyang 1st people's Hospital
ChiCTR2000029569: Canceled by the investigator Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial

Not yet recruiting
N/A
30
China
Conventional treatment ;conventional treatment combined with umbilical cord mesenchymal stem cell conditioned medium group
Xiangyang 1st People's Hospital; Xiangyang 1st People's Hospital, funding
novel coronavirus pneumonia (COVID-19)
 
 

Download Options